Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtre
1.
Int. j. cardiovasc. sci. (Impr.) ; 33(3): 299-302, May-June 2020. tab, graf
Article Dans Anglais | LILACS | ID: biblio-1134362

Résumé

Abstract The heart and lung are target organs in systemic sclerosis (SSc) and similar symptoms (dyspnea and cough) may make the differential diagnosis between the two lesions difficult. In addition, complete atrioventricular block (CAVB) is a rare complication of this disease. This case report is about a patient with SSc and pulmonary fibrosis who was admitted to the emergency room with CAVB, heart failure (HF) and progressive worsening of the underlying disease.


Sujets)
Humains , Mâle , Adulte d'âge moyen , Fibrose pulmonaire/complications , Sclérodermie diffuse/complications , Bloc atrioventriculaire/complications , Fibrose pulmonaire/diagnostic , Toux , Sclérodermie diffuse/diagnostic , Sclérodermie diffuse/traitement médicamenteux , Diagnostic précoce , Diagnostic différentiel , Dyspnée , Bloc atrioventriculaire/diagnostic , Hypertension pulmonaire
4.
Int. j. cardiovasc. sci. (Impr.) ; 28(3): 251-261, mai.-jun. 2015. tab, graf, ilus
Article Dans Portugais | LILACS | ID: lil-775248

Résumé

Lúpus eritematoso sistêmico (LES) é uma condição autoimune com processo fisiopatológico complexo, no qual sua atividade inflamatória é potencializadora da doença coronariana através de inflamação sistêmica, disfunção endotelial e predisposição à trombose. O acometimento cardiovascular no LES não é critério diagnóstico, sendo considerado somente como dano já estabelecido em longo prazo de doença. O objetivodeste artigo é destacar a importância da visão clínica para a identificação precoce do acometimento cardiovascular no LES. É feita uma análise crítica da abordagem cardiológica no LES, com ênfase nos aspectos clínicos, biomarcadores cardiovasculares e genética e solicitação racional dos exames complementares. Aparticularidade dos pacientes com nefrite lúpica e síndrome do anticorpo antifosfolipídeo também é destacada.A percepção do dano cardíaco subclínico é fundamental para interromper o ciclo de agressão miocárdica e evitar progressão de doença cardíaca.


Systemic lupus erythematosus (SLE) is an autoimmune condition with a complex pathophysiological process in which its inflammatory activity is an enhancer of coronary disease by systemic inflammation, endothelial dysfunction and predisposition to thrombosis. Thecardiovascular involvement in SLE is not a diagnostic criterion and is considered only as damage established in the long-term of the disease. The objective of this study is to highlight the importance of clinical vision for the early identification of cardiovascular involvement in SLE. A critical analysis of the cardiac approach in SLE, with emphasis on clinical aspects, cardiovascular biomarkers and genetics and rational request of additional tests. The particularity of patients with lupus nephritis and antiphospholipid antibodysyndrome is also highlighted. The perception of subclinical cardiac damage is critical for interrupting the cycle of myocardial injury and to avoid progression of heart disease.


Sujets)
Humains , Maladies auto-immunes/physiopathologie , Maladies auto-immunes/génétique , Maladies cardiovasculaires/physiopathologie , Maladies cardiovasculaires/mortalité , Lupus érythémateux disséminé/physiopathologie , Lupus érythémateux disséminé/génétique , Brésil/épidémiologie , Maladie des artères coronaires , Ethnies , Inflammation/physiopathologie , Inflammation/génétique , Prévalence , Facteurs de risque
SÉLECTION CITATIONS
Détails de la recherche